Zeng et al. (62) evaluated 4,302 ischemic stroke patients in a multicenter cohort study to determine whether plasma copeptin and NT-proBNP levels correlated with stroke recurrence within 3 months of the initial event. The gene discussed is NPPB; the disease is ischemic stroke.